http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/the-great-indian-pharma-consolidation-a-strategic-imperative-for-global-ambition/?utm_source=rss&utm_medium=rss&utm_campaign=the-great-indian-pharma-consolidation-a-strategic-imperative-for-global-ambition http://www.tapanray.in/the-great-indian-pharma-consolidation-a-strategic-imperative-for-global-ambition/#comments Fri, 04 Jul 2025 00:00:01 +0000 Tapan Ray http://www.tapanray.in/?p=10932 Continue reading →]]> http://www.tapanray.in/the-great-indian-pharma-consolidation-a-strategic-imperative-for-global-ambition/feed/ 0 http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/?utm_source=rss&utm_medium=rss&utm_campaign=the-challenge-of-holistic-value-creation-with-pharma-ma http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/#comments Mon, 19 Aug 2019 00:00:58 +0000 Tapan Ray http://www.tapanray.in/?p=9675 Continue reading →]]> http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/feed/ 0 http://www.tapanray.in/pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients/?utm_source=rss&utm_medium=rss&utm_campaign=pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients http://www.tapanray.in/pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients/#comments Mon, 28 Jan 2019 00:00:03 +0000 Tapan Ray http://www.tapanray.in/?p=9391 Continue reading →]]> http://www.tapanray.in/pharmas-oncology-focus-some-key-drivers-with-pros-and-cons-for-patients/feed/ 0 http://www.tapanray.in/drug-innovation-and-pharma-mas-a-recent-perspective/?utm_source=rss&utm_medium=rss&utm_campaign=drug-innovation-and-pharma-mas-a-recent-perspective http://www.tapanray.in/drug-innovation-and-pharma-mas-a-recent-perspective/#comments Mon, 04 Jun 2018 00:00:46 +0000 Tapan Ray http://www.tapanray.in/?p=8949 Continue reading →]]> http://www.tapanray.in/drug-innovation-and-pharma-mas-a-recent-perspective/feed/ 0 http://www.tapanray.in/key-drivers-and-long-term-impact-of-pharma-ma-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=key-drivers-and-long-term-impact-of-pharma-ma-in-india http://www.tapanray.in/key-drivers-and-long-term-impact-of-pharma-ma-in-india/#comments Mon, 21 May 2018 00:00:13 +0000 Tapan Ray http://www.tapanray.in/?p=8959 Continue reading →]]> http://www.tapanray.in/key-drivers-and-long-term-impact-of-pharma-ma-in-india/feed/ 0 http://www.tapanray.in/organic-and-inorganic-growth-strategy-for-sustainable-business-excellence/?utm_source=rss&utm_medium=rss&utm_campaign=organic-and-inorganic-growth-strategy-for-sustainable-business-excellence http://www.tapanray.in/organic-and-inorganic-growth-strategy-for-sustainable-business-excellence/#comments Mon, 30 Apr 2018 00:00:10 +0000 Tapan Ray http://www.tapanray.in/?p=8936 Continue reading →]]> http://www.tapanray.in/organic-and-inorganic-growth-strategy-for-sustainable-business-excellence/feed/ 0 http://www.tapanray.in/discretionary-non-compete-clause-in-pharma-fdi-an-intriguing-decision/?utm_source=rss&utm_medium=rss&utm_campaign=discretionary-non-compete-clause-in-pharma-fdi-an-intriguing-decision http://www.tapanray.in/discretionary-non-compete-clause-in-pharma-fdi-an-intriguing-decision/#comments Fri, 10 Jan 2014 07:05:52 +0000 Tapan Ray http://www.tapanray.in/?p=4848 Continue reading →]]> http://www.tapanray.in/discretionary-non-compete-clause-in-pharma-fdi-an-intriguing-decision/feed/ 0 http://www.tapanray.in/pharma-fdi-damning-report-of-parliamentary-panel-pm-vetoes-and-avoids-ruffling-feathers/?utm_source=rss&utm_medium=rss&utm_campaign=pharma-fdi-damning-report-of-parliamentary-panel-pm-vetoes-and-avoids-ruffling-feathers http://www.tapanray.in/pharma-fdi-damning-report-of-parliamentary-panel-pm-vetoes-and-avoids-ruffling-feathers/#comments Mon, 19 Aug 2013 00:00:00 +0000 Tapan Ray http://www.tapanray.in/?p=3241 Continue reading →]]> http://www.tapanray.in/pharma-fdi-damning-report-of-parliamentary-panel-pm-vetoes-and-avoids-ruffling-feathers/feed/ 0 http://www.tapanray.in/could-mas-in-pharma-create-significant-stakeholder-value/?utm_source=rss&utm_medium=rss&utm_campaign=could-mas-in-pharma-create-significant-stakeholder-value http://www.tapanray.in/could-mas-in-pharma-create-significant-stakeholder-value/#comments Mon, 25 Apr 2011 01:00:33 +0000 Tapan Ray http://tapanray.in/index.php/?p=269 Continue reading →]]> http://www.tapanray.in/could-mas-in-pharma-create-significant-stakeholder-value/feed/ 0 http://www.tapanray.in/a-time-to-keep-our-nose-to-the-grindstone-competition-act-will-take-care-of-mas-come-june-2011/?utm_source=rss&utm_medium=rss&utm_campaign=a-time-to-keep-our-nose-to-the-grindstone-competition-act-will-take-care-of-mas-come-june-2011 http://www.tapanray.in/a-time-to-keep-our-nose-to-the-grindstone-competition-act-will-take-care-of-mas-come-june-2011/#comments Mon, 14 Mar 2011 00:30:24 +0000 Tapan Ray http://tapanray.in/index.php/?p=290 Continue reading →]]> http://www.tapanray.in/a-time-to-keep-our-nose-to-the-grindstone-competition-act-will-take-care-of-mas-come-june-2011/feed/ 0